[Bridgewater, NJ] (PRWEB) March 31, 2023 RVL Pharmaceuticals announced today that its prescription eye drop Upneeq® (oxymetazoline hydrochloride ophthalmic
03.04.2023 - Selected from 10,000 EntrantsBRIDGEWATER, N.J., April 03, 2023 (GLOBE NEWSWIRE) - RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”) announced today that its prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic . Seite 1
[Bridgewater, NJ] (PRWEB) March 31, 2023 RVL Pharmaceuticals announced today that its prescription eye drop Upneeq® (oxymetazoline hydrochloride ophthalmic
/PRNewswire/ RVL Pharmaceuticals plc (Nasdaq: RVLP) announced today that its U.S. FDA approved acquired blepharoptosis (ptosis) drug UPNEEQ® (oxymetazoline.